ID   AGRL3_MOUSE             Reviewed;        1537 AA.
AC   Q80TS3; Q3UHI7; Q3UM79; Q504Z9; Q5HZJ6; Q80T56;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 164.
DE   RecName: Full=Adhesion G protein-coupled receptor L3 {ECO:0000312|MGI:MGI:2441950};
DE   AltName: Full=Latrophilin-3 {ECO:0000312|MGI:MGI:2441950};
DE   AltName: Full=Lectomedin-3 {ECO:0000312|MGI:MGI:2441950};
DE   Flags: Precursor;
GN   Name=Adgrl3 {ECO:0000312|MGI:MGI:2441950};
GN   Synonyms=Kiaa0768 {ECO:0000312|MGI:MGI:2441950}, Lec3
GN   {ECO:0000312|MGI:MGI:2441950}, Lphn3 {ECO:0000312|MGI:MGI:2441950};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 672-1537 (ISOFORM 5).
RC   STRAIN=C57BL/6J; TISSUE=Mammary gland;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 6).
RC   STRAIN=C57BL/6J; TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 481-1537 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 803-981.
RX   PubMed=12679517; DOI=10.1073/pnas.0230374100;
RA   Vassilatis D.K., Hohmann J.G., Zeng H., Li F., Ranchalis J.E.,
RA   Mortrud M.T., Brown A., Rodriguez S.S., Weller J.R., Wright A.C.,
RA   Bergmann J.E., Gaitanaris G.A.;
RT   "The G protein-coupled receptor repertoires of human and mouse.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4903-4908(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1254 AND SER-1522, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=22575564; DOI=10.1016/j.brainres.2012.04.053;
RA   Wallis D., Hill D.S., Mendez I.A., Abbott L.C., Finnell R.H., Wellman P.J.,
RA   Setlow B.;
RT   "Initial characterization of mice null for Lphn3, a gene implicated in ADHD
RT   and addiction.";
RL   Brain Res. 1463:85-92(2012).
RN   [7]
RP   INTERACTION WITH TENM3; FLRT1; FLRT2 AND FLRT3, SUBCELLULAR LOCATION, AND
RP   FUNCTION.
RX   PubMed=22405201; DOI=10.1016/j.neuron.2012.01.018;
RA   O'Sullivan M.L., de Wit J., Savas J.N., Comoletti D., Otto-Hitt S.,
RA   Yates J.R. III, Ghosh A.;
RT   "FLRT proteins are endogenous latrophilin ligands and regulate excitatory
RT   synapse development.";
RL   Neuron 73:903-910(2012).
RN   [8]
RP   FUNCTION, GLYCOSYLATION, INTERACTION WITH FLRT3 AND TENM1, DOMAIN, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24739570; DOI=10.1186/1749-8104-9-7;
RA   O'Sullivan M.L., Martini F., von Daake S., Comoletti D., Ghosh A.;
RT   "LPHN3, a presynaptic adhesion-GPCR implicated in ADHD, regulates the
RT   strength of neocortical layer 2/3 synaptic input to layer 5.";
RL   Neural Dev. 9:7-7(2014).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 97-459 IN COMPLEX WITH CALCIUM
RP   IONS, FUNCTION, INTERACTION WITH FLRT2, DISULFIDE BONDS, GLYCOSYLATION AT
RP   ASN-161, AND MUTAGENESIS OF PRO-244; ARG-246; THR-267; LYS-269; ARG-292;
RP   ARG-294; ARG-324 AND GLY-326.
RX   PubMed=25728924; DOI=10.1016/j.str.2015.01.013;
RA   Jackson V.A., del Toro D., Carrasquero M., Roversi P., Harlos K., Klein R.,
RA   Seiradake E.;
RT   "Structural basis of latrophilin-FLRT interaction.";
RL   Structure 23:774-781(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 199-495 IN COMPLEX WITH FLRT3 AND
RP   CALCIUM IONS, INTERACTION WITH FLRT3, AND MUTAGENESIS OF TYR-323 AND
RP   ASP-332.
RX   PubMed=26235031; DOI=10.1016/j.str.2015.06.022;
RA   Ranaivoson F.M., Liu Q., Martini F., Bergami F., von Daake S., Li S.,
RA   Lee D., Demeler B., Hendrickson W.A., Comoletti D.;
RT   "Structural and mechanistic insights into the latrophilin3-FLRT3 complex
RT   that mediates glutamatergic synapse development.";
RL   Structure 23:1665-1677(2015).
CC   -!- FUNCTION: Plays a role in cell-cell adhesion and neuron guidance via
CC       its interactions with FLRT2 and FLRT3 that are expressed at the surface
CC       of adjacent cells (PubMed:22405201, PubMed:25728924, PubMed:26235031).
CC       Plays a role in the development of glutamatergic synapses in the cortex
CC       (PubMed:22405201, PubMed:24739570). Important in determining the
CC       connectivity rates between the principal neurons in the cortex
CC       (PubMed:24739570). {ECO:0000269|PubMed:22405201,
CC       ECO:0000269|PubMed:24739570, ECO:0000269|PubMed:25728924,
CC       ECO:0000269|PubMed:26235031}.
CC   -!- SUBUNIT: Interacts (via olfactomedin-like domain) with FLRT3 (via
CC       extracellular domain); the interaction is direct(PubMed:22405201,
CC       PubMed:24739570, PubMed:26235031). Identified in a complex with FLRT3
CC       and UNC5B; does not interact with UNC5B by itself. Identified in a
CC       complex with FLRT3 and UNC5D; does not interact with UNC5D by itself
CC       (By similarity). Interacts (via olfactomedin-like domain) with FLRT1
CC       (via extracellular domain) (PubMed:22405201). Interacts (via
CC       olfactomedin-like domain) with FLRT2 (via extracellular domain)
CC       (PubMed:22405201, PubMed:25728924). Interacts (via extracellular
CC       domain) with TENM1 (PubMed:24739570). Interacts (via extracellular
CC       domain) with TENM3 (PubMed:22405201). {ECO:0000250|UniProtKB:Q9HAR2,
CC       ECO:0000269|PubMed:22405201, ECO:0000269|PubMed:24739570,
CC       ECO:0000269|PubMed:25728924, ECO:0000269|PubMed:26235031}.
CC   -!- INTERACTION:
CC       Q80TS3; Q8BLU0: Flrt2; NbExp=2; IntAct=EBI-770665, EBI-16146541;
CC       Q80TS3; Q8BGT1: Flrt3; NbExp=6; IntAct=EBI-770665, EBI-16166902;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22405201,
CC       ECO:0000269|PubMed:24739570}; Multi-pass membrane protein
CC       {ECO:0000305}. Cell projection, axon {ECO:0000269|PubMed:22405201}.
CC       Cell junction {ECO:0000269|PubMed:22405201}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q80TS3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q80TS3-2; Sequence=VSP_010121, VSP_010122, VSP_010123;
CC       Name=3;
CC         IsoId=Q80TS3-3; Sequence=VSP_022142;
CC       Name=4;
CC         IsoId=Q80TS3-4; Sequence=VSP_022138;
CC       Name=5;
CC         IsoId=Q80TS3-5; Sequence=VSP_010121;
CC       Name=6;
CC         IsoId=Q80TS3-6; Sequence=VSP_022139, VSP_022140, VSP_022141;
CC   -!- DOMAIN: The Olfactomedin-like domain is required for the synapse-
CC       promoting function and the interaction with FLRT3. The Olfactomedin-
CC       like and the SUEL-type lectin domains are required for the interaction
CC       with TENM1. {ECO:0000269|PubMed:24739570}.
CC   -!- PTM: Proteolytically cleaved into 2 subunits, an extracellular subunit
CC       and a seven-transmembrane subunit. {ECO:0000250}.
CC   -!- PTM: O-glycosylated (major) and N-glycosylated.
CC       {ECO:0000269|PubMed:24739570}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice are viable and present no obvious
CC       physical phenotype. Compared to wild-type, mutants are hyperactive, and
CC       their dorsal striatum contains higher levels of the neurotransmitters
CC       dopamine and serotonin. Cocaine treatment causes a higher increase in
CC       locomotor activity than in wild-type. {ECO:0000269|PubMed:22575564}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family. LN-TM7
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK145069; BAE26219.1; -; mRNA.
DR   EMBL; AK147374; BAE27870.1; -; mRNA.
DR   EMBL; BC058992; AAH58992.1; -; mRNA.
DR   EMBL; BC088989; AAH88989.1; -; mRNA.
DR   EMBL; BC094668; AAH94668.1; -; mRNA.
DR   EMBL; AK122367; BAC65649.1; -; mRNA.
DR   EMBL; AY255584; AAO85096.1; -; mRNA.
DR   CCDS; CCDS39122.1; -. [Q80TS3-3]
DR   CCDS; CCDS84894.1; -. [Q80TS3-5]
DR   RefSeq; NP_001334298.1; NM_001347369.1. [Q80TS3-5]
DR   RefSeq; NP_941991.1; NM_198702.2. [Q80TS3-3]
DR   RefSeq; XP_011247767.1; XM_011249465.2. [Q80TS3-3]
DR   RefSeq; XP_011247768.1; XM_011249466.2.
DR   RefSeq; XP_011247773.1; XM_011249471.2. [Q80TS3-2]
DR   RefSeq; XP_017176402.1; XM_017320913.1.
DR   PDB; 4RMK; X-ray; 1.61 A; A=199-495.
DR   PDB; 4RML; X-ray; 1.60 A; A=199-495.
DR   PDB; 4YEB; X-ray; 3.19 A; A=199-495.
DR   PDB; 5AFB; X-ray; 2.16 A; A=97-459.
DR   PDB; 5FTT; X-ray; 3.40 A; C/D/G/H=92-463.
DR   PDB; 5FTU; X-ray; 6.01 A; C/D/G/H/K/L=92-463.
DR   PDB; 6JBU; X-ray; 1.85 A; A=203-461.
DR   PDBsum; 4RMK; -.
DR   PDBsum; 4RML; -.
DR   PDBsum; 4YEB; -.
DR   PDBsum; 5AFB; -.
DR   PDBsum; 5FTT; -.
DR   PDBsum; 5FTU; -.
DR   PDBsum; 6JBU; -.
DR   AlphaFoldDB; Q80TS3; -.
DR   SMR; Q80TS3; -.
DR   BioGRID; 235241; 5.
DR   DIP; DIP-32218N; -.
DR   IntAct; Q80TS3; 4.
DR   MINT; Q80TS3; -.
DR   STRING; 10090.ENSMUSP00000113482; -.
DR   MEROPS; P02.011; -.
DR   GlyConnect; 2419; 9 N-Linked glycans (5 sites). [Q80TS3-2]
DR   GlyGen; Q80TS3; 10 sites, 9 N-linked glycans (5 sites).
DR   iPTMnet; Q80TS3; -.
DR   PhosphoSitePlus; Q80TS3; -.
DR   SwissPalm; Q80TS3; -.
DR   MaxQB; Q80TS3; -.
DR   PaxDb; Q80TS3; -.
DR   PeptideAtlas; Q80TS3; -.
DR   PRIDE; Q80TS3; -.
DR   ProteomicsDB; 285776; -. [Q80TS3-1]
DR   ProteomicsDB; 285777; -. [Q80TS3-2]
DR   ProteomicsDB; 285778; -. [Q80TS3-3]
DR   ProteomicsDB; 285779; -. [Q80TS3-4]
DR   ProteomicsDB; 285780; -. [Q80TS3-5]
DR   ProteomicsDB; 285781; -. [Q80TS3-6]
DR   Antibodypedia; 2755; 176 antibodies from 31 providers.
DR   DNASU; 319387; -.
DR   Ensembl; ENSMUST00000072521; ENSMUSP00000072336; ENSMUSG00000037605. [Q80TS3-3]
DR   Ensembl; ENSMUST00000117407; ENSMUSP00000112388; ENSMUSG00000037605. [Q80TS3-2]
DR   Ensembl; ENSMUST00000122356; ENSMUSP00000113600; ENSMUSG00000037605. [Q80TS3-5]
DR   GeneID; 319387; -.
DR   KEGG; mmu:319387; -.
DR   UCSC; uc008xwk.1; mouse. [Q80TS3-6]
DR   UCSC; uc008xwn.1; mouse. [Q80TS3-1]
DR   UCSC; uc008xwp.1; mouse. [Q80TS3-3]
DR   CTD; 23284; -.
DR   MGI; MGI:2441950; Adgrl3.
DR   VEuPathDB; HostDB:ENSMUSG00000037605; -.
DR   eggNOG; KOG3545; Eukaryota.
DR   eggNOG; KOG4193; Eukaryota.
DR   eggNOG; KOG4729; Eukaryota.
DR   GeneTree; ENSGT00940000155527; -.
DR   InParanoid; Q80TS3; -.
DR   OrthoDB; 388923at2759; -.
DR   PhylomeDB; Q80TS3; -.
DR   BioGRID-ORCS; 319387; 3 hits in 57 CRISPR screens.
DR   ChiTaRS; Adgrl3; mouse.
DR   PRO; PR:Q80TS3; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; Q80TS3; protein.
DR   Bgee; ENSMUSG00000037605; Expressed in CA1 field of hippocampus and 178 other tissues.
DR   ExpressionAtlas; Q80TS3; baseline and differential.
DR   Genevisible; Q80TS3; MM.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0098742; P:cell-cell adhesion via plasma-membrane adhesion molecules; IMP:UniProtKB.
DR   GO; GO:0031987; P:locomotion involved in locomotory behavior; IMP:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; IMP:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IDA:MGI.
DR   GO; GO:0042220; P:response to cocaine; IMP:UniProtKB.
DR   GO; GO:0007416; P:synapse assembly; IMP:UniProtKB.
DR   GO; GO:0050808; P:synapse organization; IDA:SynGO.
DR   Gene3D; 2.60.120.740; -; 1.
DR   Gene3D; 2.60.220.50; -; 1.
DR   Gene3D; 4.10.1240.10; -; 1.
DR   InterPro; IPR032471; GAIN_dom_N.
DR   InterPro; IPR046338; GAIN_dom_sf.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR003924; GPCR_2_latrophilin.
DR   InterPro; IPR003334; GPCR_2_latrophilin_rcpt_C.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR015630; Latrophilin-3.
DR   InterPro; IPR000922; Lectin_gal-bd_dom.
DR   InterPro; IPR043159; Lectin_gal-bd_sf.
DR   InterPro; IPR003112; Olfac-like_dom.
DR   PANTHER; PTHR12011:SF60; PTHR12011:SF60; 1.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF16489; GAIN; 1.
DR   Pfam; PF02140; Gal_Lectin; 1.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF02354; Latrophilin; 2.
DR   Pfam; PF02191; OLF; 1.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   PRINTS; PR01444; LATROPHILIN.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00008; HormR; 1.
DR   SMART; SM00284; OLF; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GPS; 1.
DR   PROSITE; PS51132; OLF; 1.
DR   PROSITE; PS50228; SUEL_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell junction; Cell membrane;
KW   Cell projection; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Lectin; Membrane; Metal-binding; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1537
FT                   /note="Adhesion G protein-coupled receptor L3"
FT                   /id="PRO_0000070344"
FT   TOPO_DOM        20..949
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        950..970
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        971..978
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        979..999
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1000..1007
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1008..1028
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1029..1050
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1051..1071
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1072..1088
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1089..1109
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1110..1142
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1143..1163
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1164..1169
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1170..1190
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1191..1537
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          103..192
FT                   /note="SUEL-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00260"
FT   DOMAIN          202..461
FT                   /note="Olfactomedin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00446"
FT   DOMAIN          883..934
FT                   /note="GPS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   REGION          53..80
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          317..347
FT                   /note="Interaction with FLRT3"
FT   REGION          521..540
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1213..1237
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1512..1537
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         332
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   BINDING         380
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   BINDING         381
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   BINDING         435
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MOD_RES         1254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CARBOHYD        161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:25728924,
FT                   ECO:0007744|PDB:5AFB"
FT   CARBOHYD        532
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        617
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        827
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        840
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        885
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        911
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1000
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        104..134
FT                   /evidence="ECO:0007744|PDB:5AFB"
FT   DISULFID        113..191
FT                   /evidence="ECO:0007744|PDB:5AFB"
FT   DISULFID        146..178
FT                   /evidence="ECO:0007744|PDB:5AFB"
FT   DISULFID        159..165
FT                   /evidence="ECO:0007744|PDB:5AFB"
FT   DISULFID        203..385
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00446,
FT                   ECO:0007744|PDB:5AFB"
FT   VAR_SEQ         1..239
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_022138"
FT   VAR_SEQ         195..200
FT                   /note="KVEQKV -> I (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022139"
FT   VAR_SEQ         650
FT                   /note="H -> Q (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022140"
FT   VAR_SEQ         651..1537
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022141"
FT   VAR_SEQ         1132..1140
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_010121"
FT   VAR_SEQ         1272..1351
FT                   /note="EGLLNNARDTSVMDTLPLNGNHGNSYSIAGGEYLSNCVQIIDRGYNHNETAL
FT                   EKKILKELTSNYIPSYLNNHERSSEQNR -> GAMANHLISNALLRPHGTNNPYNTLLG
FT                   EPAVCNNPSISMYNTQEPYRETSMGVKLNIAYQIGASEQCQGYKCHGYSTTEW (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010122"
FT   VAR_SEQ         1272
FT                   /note="E -> EPYRETK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022142"
FT   VAR_SEQ         1352..1537
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010123"
FT   MUTAGEN         244
FT                   /note="P->N: Strongly reduces FLRT2 binding; when
FT                   associated with T-246."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         246
FT                   /note="R->T: Strongly reduces FLRT2 binding; when
FT                   associated with N-244."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         267
FT                   /note="T->N: Strongly reduces FLRT2 binding; when
FT                   associated with T-269."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         269
FT                   /note="K->T: Strongly reduces FLRT2 binding; when
FT                   associated with N-267."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         292
FT                   /note="R->N: Abolishes interaction with FLRT2; when
FT                   associated with T-294."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         294
FT                   /note="R->T: Abolishes interaction with FLRT2; when
FT                   associated with N-292."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         323
FT                   /note="Y->A: Abolishes FLRT3 binding."
FT                   /evidence="ECO:0000269|PubMed:26235031"
FT   MUTAGEN         324
FT                   /note="R->N: Abolishes interaction with FLRT2; when
FT                   associated with T-326."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         326
FT                   /note="G->T: Abolishes interaction with FLRT2; when
FT                   associated with N-324."
FT                   /evidence="ECO:0000269|PubMed:25728924"
FT   MUTAGEN         332
FT                   /note="D->A: Strongly reduces FLRT3 binding."
FT                   /evidence="ECO:0000269|PubMed:26235031"
FT   CONFLICT        381
FT                   /note="A -> S (in Ref. 2; AAH94668)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1252
FT                   /note="K -> R (in Ref. 1; BAE27870)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1375
FT                   /note="A -> T (in Ref. 1; BAE26219)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1495
FT                   /note="V -> M (in Ref. 1; BAE26219)"
FT                   /evidence="ECO:0000305"
FT   STRAND          101..104
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          108..112
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          118..129
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          131..134
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   TURN            138..141
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   HELIX           151..158
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   TURN            159..161
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          163..168
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   TURN            171..173
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          184..192
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          199..202
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          206..218
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          220..227
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:5FTT"
FT   STRAND          237..241
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   TURN            244..246
FT                   /evidence="ECO:0007829|PDB:6JBU"
FT   STRAND          249..255
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   HELIX           256..261
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          265..269
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          274..277
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          280..282
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          285..290
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          293..300
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   TURN            301..304
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          305..311
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          318..321
FT                   /evidence="ECO:0007829|PDB:4RMK"
FT   STRAND          330..336
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          339..346
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   TURN            347..351
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          352..358
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   TURN            360..362
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          365..374
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   HELIX           375..377
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          378..384
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          387..393
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          405..412
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   TURN            413..416
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          417..424
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          428..430
FT                   /evidence="ECO:0007829|PDB:6JBU"
FT   STRAND          434..438
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   TURN            439..442
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          443..448
FT                   /evidence="ECO:0007829|PDB:4RML"
FT   STRAND          451..460
FT                   /evidence="ECO:0007829|PDB:4RML"
SQ   SEQUENCE   1537 AA;  171080 MW;  F55EAB142C987A69 CRC64;
     MWPPQLLILT MLLAPVVHGG KHNERHPALA APLRHAERSP GGALPPRHLL QQPAAERSTA
     HRGQGPRGAA RGVRGPGAPG AQIAAQAFSR APIPMAVVRR ELSCESYPIE LRCPGTDVIM
     IESANYGRTD DKICDSDPAQ MENIRCYLPD AYKIMSQRCN NRTQCAVVAG PDVFPDPCPG
     TYKYLEVQYE CVPYKVEQKV FLCPGLLKGV YQSEHLFESD HQSGAWCKDP LQASDKIYYM
     PWTPYRTDTL TEYSSKDDFI AGRPTTTYKL PHRVDGTGFV VYDGALFFNK ERTRNIVKFD
     LRTRIKSGEA IIANANYHDT SPYRWGGKSD IDLAVDENGL WVIYATEQNN GKIVISQLNP
     YTLRIEGTWD TAYDKRSASN AFMICGILYV VKSVYEDDDN EATGNKIDYI YNTDQSKDSL
     VDVPFPNSYQ YIAAVDYNPR DNLLYVWNNY HVVKYSLDFG PLDSRSGPVH HGQVSYISPP
     IHLDSELERP PVRGISTTGS LGMGSTTTST TLRTTTWNIG RSTTASLPGR RNRSTSTPSP
     AVEVLDDVTT HLPSAASQIP AMEESCEAVE AREIMWFKTR QGQVAKQPCP AGTIGVSTYL
     CLAPDGIWDP QGPDLSNCSS PWVNHITQKL KSGETAANIA RELAEQTRNH LNAGDITYSV
     RAMDQLVGLL DVQLRNLTPG GKDSAARSLN KLQKRERSCR AYVQAMVETV NNLLQPQALN
     AWRDLTTSDQ LRAATMLLDT VEESAFVLAD NLLKTDIVRE NTDNIQLEVA RLSTEGNLED
     LKFPENMGHG STIQLSANTL KQNGRNGEIR VAFVLYNNLG PYLSTENASM KLGTEAMSTN
     HSVIVNSPVI TAAINKEFSN KVYLADPVVF TVKHIKQSEE NFNPNCSFWS YSKRTMTGYW
     STQGCRLLTT NKTHTTCSCN HLTNFAVLMA HVEVKHSDAV HDLLLDVITW VGILLSLVCL
     LICIFTFCFF RGLQSDRNTI HKNLCISLFV AELLFLIGIN RTDQPIACAV FAALLHFFFL
     AAFTWMFLEG VQLYIMLVEV FESEHSRRKY FYLVGYGMPA LIVAVSAAVD YRSYGTDKVC
     WLRLDTYFIW SFIGPATLII MLNVIFLGIA LYKMFHHTAI LKPESGCLDN INYEDNRPFI
     KSWVIGAIAL LCLLGLTWAF GLMYINESTV IMAYLFTIFN SLQGMFIFIF HCVLQKKVRK
     EYGKCLRTHC CSGKSTESSI GSGKTSGSRT PGRYSTGSQS RIRRMWNDTV RKQSESSFIT
     GDINSSASLN REGLLNNARD TSVMDTLPLN GNHGNSYSIA GGEYLSNCVQ IIDRGYNHNE
     TALEKKILKE LTSNYIPSYL NNHERSSEQN RNMMNKLVNN LGSGSEDDAI VLDDAASFNH
     EESLGLELIH EESDAPLLPP RVYSTDNHQP HHYSRRRFPQ DHSESFFPLL TDEHTEDLQS
     PHRDSLYTSM PALAGVPAAD SVTTSTQTEA AAAKGGDAED VYYKSMPNLG SRNHVHPLHA
     YYQLGRGSSD GFIVPPNKDG ASPEGTSKGP AHLVTSL
//
